TAKEDA CAMBRIDGE LIMITED
Get an alert when TAKEDA CAMBRIDGE LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-12-31 (in 7mo)
Last filed for 2025-03-31
Confirmation statement due
2026-07-07 (in 2mo)
Last made up 2025-06-23
Watchouts
None on the register
Cash
£684K
-42.3% vs 2024
Net assets
£4M
+9.7% vs 2024
Employees
—
Average over period
Profit before tax
£468K
+94.2% vs 2024
Name history
Renamed 1 time since incorporation
- TAKEDA CAMBRIDGE LIMITED 2007-03-30 → present
- PARADIGM THERAPEUTICS LIMITED 1998-06-23 → 2007-03-30
Net assets
2-year trend · vs Real Estate median
Accounts
2-year trend · latest reflected 2025-03-31
| Metric | Trend | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Turnover | £1,745,000 | £1,745,000 | |
| Operating profit | £277,000 | £436,000 | |
| Profit before tax | £241,000 | £468,000 | |
| Net profit | £221,000 | £342,000 | |
| Cash | £1,185,000 | £684,000 | |
| Total assets less current liabilities | £11,718,000 | £10,837,000 | |
| Net assets | £3,516,000 | £3,858,000 | |
| Equity | £3,516,000 | £3,858,000 | |
| Average employees | — | — | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Operating margin | 15.9% | 25.0% | |
| Net margin | 12.7% | 19.6% | |
| Return on capital employed | 2.4% | 4.0% | |
| Gearing (liabilities / total assets) | 74.2% | 69.4% | |
| Current ratio | 4.01x | 4.25x | |
| Interest cover | 1.01x | 1.81x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- KPMG LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Auditor concurs with directors' assessment that there is no material uncertainty related to events or conditions that, individually or collectively, may cast significant doubt over the Company's ability to continue as a going concern for at least a year from the date of approval of the financial statements.”
Significant events
- “There have been no significant events since the end of the financial year.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 36 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| DRISCOLL, Bryan Joseph | Secretary | 2017-04-30 | — | — |
| MEMIS, Seyda Atadan | Director | 2025-08-31 | Mar 1979 | Turkish |
| MIURA, Itaru | Director | 2025-11-04 | Nov 1975 | Japanese |
| PAGE, Marc Stuart | Director | 2021-04-28 | Feb 1985 | British |
Show 36 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CARLTON, Mark Beresford Lewis, Doctor | Secretary | 1998-06-23 | 1998-07-01 |
| COX, Charles Fahie Mckay | Secretary | 1998-07-01 | 2001-11-19 |
| SUTCLIFFE, James Holden | Secretary | 2001-11-19 | 2017-04-30 |
| MIDLANDS COMPANY SERVICES LIMITED | Corporate Secretary | 1998-06-23 | 1998-06-23 |
| ADEY, Jane | Director | 1998-06-23 | 1998-06-23 |
| APARICIO, Samuel Alves Jana Rodrigues, Dr | Director | 1998-06-23 | 2004-12-24 |
| CARLTON, Mark Beresford Lewis, Dr | Director | 2009-08-10 | 2016-12-01 |
| CARLTON, Mark Beresford Lewis, Dr | Director | 1998-06-23 | 2007-03-29 |
| CLEMENT, Mark Rowland | Director | 2004-12-24 | 2005-08-18 |
| COX, Charles Fahie Mckay | Director | 1998-07-01 | 2002-11-29 |
| DOUEK, Rony, Dr | Director | 2006-03-27 | 2007-03-29 |
| FOWLER, Mark Conrad | Director | 2016-12-01 | 2020-09-25 |
| GOODFELLOW, Richard Morley, Doctor | Director | 1998-07-01 | 2003-07-30 |
| GOODMAN, Alan Gilbert | Director | 2000-12-11 | 2006-09-22 |
| GOUGH, David Anthony | Director | 2000-12-11 | 2002-03-28 |
| GRAY, Ian Christopher, Dr | Director | 2011-08-15 | 2014-03-31 |
| GRUBIN, Peter Michael | Director | 2022-12-13 | 2025-08-31 |
| HUGHES, Robert Graham, Dr | Director | 2002-11-29 | 2003-11-30 |
| ISAACS, David | Director | 2016-12-01 | 2021-06-30 |
| ISHIHARA, Yuji | Director | 2010-03-09 | 2011-08-15 |
| KENNY, Barry Aidan, Dr | Director | 2003-09-01 | 2007-03-29 |
| KITAZAWA, Kiyoshi, Dr | Director | 2007-03-29 | 2009-08-10 |
| LIM, Jui, Dr | Director | 2006-03-27 | 2007-03-29 |
| MARUYAMA, Tetsuyuki, Dr | Director | 2011-08-15 | 2015-12-31 |
| MIYAMOTO, Masaomi | Director | 2007-03-29 | 2010-03-09 |
| MONTANA, John Gary, Dr | Director | 2004-12-24 | 2005-11-30 |
| MOSES, Edwin, Dr | Director | 2003-09-29 | 2006-03-01 |
| MUNRO, Alan James, Dr | Director | 2002-11-29 | 2007-03-29 |
| ODAKA, Hiroyuki, Dr | Director | 2009-08-10 | 2011-08-15 |
| OKAWA, Shigenori | Director | 2007-03-29 | 2009-08-10 |
| REID, Charmaine Linda | Director | 2020-09-29 | 2022-08-31 |
| RIDDELL, Alastair James, Dr | Director | 2005-05-18 | 2007-03-29 |
| ROACH, Daniel James William | Director | 2002-03-28 | 2002-11-29 |
| RUSS, Andreas Peter, Dr | Director | 1998-06-23 | 2000-12-08 |
| SPICER, Andrew Raymond | Director | 2017-12-19 | 2024-05-31 |
| SUTCLIFFE, James Holden | Director | 2014-12-01 | 2017-04-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Takeda Pharmaceutical Company Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 222 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-01-04 | AA | accounts | Accounts with accounts type full | |
| 2025-11-07 | AP01 | officers | Appoint person director company with name date | |
| 2025-09-08 | AP01 | officers | Appoint person director company with name date | |
| 2025-09-05 | TM01 | officers | Termination director company with name termination date | |
| 2025-07-11 | CH01 | officers | Change person director company with change date | |
| 2025-06-27 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-12-31 | AA | accounts | Accounts with accounts type full | |
| 2024-06-24 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-06-03 | TM01 | officers | Termination director company with name termination date | |
| 2024-05-13 | AA | accounts | Accounts with accounts type full | |
| 2023-06-26 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-04-08 | AA | accounts | Accounts with accounts type full | |
| 2022-12-15 | AP01 | officers | Appoint person director company with name date | |
| 2022-09-12 | TM01 | officers | Termination director company with name termination date | |
| 2022-06-27 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-04-06 | AA | accounts | Accounts with accounts type full | |
| 2021-07-08 | TM01 | officers | Termination director company with name termination date | |
| 2021-06-23 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-04-28 | AP01 | officers | Appoint person director company with name date | |
| 2021-03-26 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 6
- Capital events
- 0
- Officers appointed
- 2
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2024 → FY2025 · period ending 2025-03-31 vs 2024-03-31
-
Turnover
0%
£1,745,000 £1,745,000
-
Cash
-42.3%
£1,185,000 £684,000
-
Net assets
+9.7%
£3,516,000 £3,858,000
-
Employees
—
Not reported
-
Operating profit
+57.4%
£277,000 £436,000
-
Profit before tax
+94.2%
£241,000 £468,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers